Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

NCT03801915 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Colon Cancer
Pancreatic Cancer
Cholangiocarcinoma
Metastatic Colon Carcinoma
Liver Metastasis

Interventions

DRUG: MVT-5873
PROCEDURE: pancreatectomy or hepatectomy

Sponsor

National Cancer Institute (NCI)